WebAug 26, 2024 · Modalis raised ¥3.7 billion ($35.2 million) in its IPO via the sale of 3.1 million shares at ¥1,200, the top of its proposed range. Biotechs are a rarity on Mothers; the last to list was regenerative medicine play StemRIM Inc. (Tokyo:4599), which raised ¥9.7 billion in an IPO last August through the sale of 9.7 million shares at ¥1,000. WebMar 13, 2024 · Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation,...
Astellas Pharma - Wikipedia
Web1 day ago · A company with a spacecraft en route to the moon, ispace is now trading on the Tokyo Stock Exchange. The Japanese firm raised around $52 million (¥6.7 billion) in an initial public offering last ... Web19 hours ago · Tokyo Electron (TOEL.Y-3.59%) receives little coverage or fanfare, yet it is a dominant force in the semiconductor manufacturing world. Indeed, it is among the five largest suppliers of chip fab ... thiamine treatment uptodate
Astellas Pharma, Inc. ALPMF Company - Stock Info #980203
WebAstellas Pharma Inc. Stock Price Today TYO 4503 Live Ticker - Investing.com Stock Screener United States Pre-Market World ADRs Stock Brokers Americas Europe Middle … WebMar 13, 2024 · TOKYO--Astellas Pharma Inc. (4503.TO) said Tuesday it will book a special loss of Y11 billion ($108 million) in the current fiscal year ending March 2014 as it takes … WebMar 27, 2024 · Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The … thiamine transporter 1